Crown ethers attenuate aggregation of amyloid beta of Alzheimer's disease

被引:27
|
作者
Tian, Yanli [1 ,2 ]
Zhang, Xueli [1 ,3 ,4 ]
Li, Yuyan [1 ,3 ]
Shoup, Timothy M. [5 ]
Teng, Xin [5 ]
Elmaleh, David R. [5 ]
Moore, Anna [1 ]
Ran, Chongzhao [1 ]
机构
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Mol Imaging Lab,AA Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA
[2] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Parasitol, Guangzhou 510275, Guangdong, Peoples R China
[3] China Pharmaceut Univ, Sch Pharm, Nanjing, Jiangsu, Peoples R China
[4] Southeast Univ, ZhongDa Hosp, Dept Pharm, Nanjing, Jiangsu, Peoples R China
[5] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Nucl Med & Mol Imaging,Dept Radiol, Boston, MA USA
关键词
MOLECULAR RECOGNITION; PEPTIDE; FIBRILS; BINDING; MECHANISM; OLIGOMERS;
D O I
10.1039/c4cc06029f
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In this report, we reasoned that non-covalent modification of amyloid beta (Ab) by crown ethers could inhibit its aggregation. We demonstrated that PiB-C, a conjugate PiB and crown ether, could significantly reduce the aggregation in vitro. Additionally, two-photon imaging showed that PiB-C could efficiently label Ab plaques and CAAs in AD mice.
引用
收藏
页码:15792 / 15795
页数:4
相关论文
共 50 条
  • [1] Effects of aluminum on amyloid-beta aggregation in the context of Alzheimer's disease
    Zhang, Qiulan
    Zhang, Fangyuan
    Ni, Yongnian
    Kokot, Serge
    ARABIAN JOURNAL OF CHEMISTRY, 2019, 12 (08) : 2897 - 2904
  • [2] Studies of a beta-hairpin peptide model for the amyloid beta aggregation in Alzheimer's disease
    Baker, GA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U27 - U27
  • [3] Effects of different solvents in the aggregation of Alzheimer's disease beta amyloid peptide.
    Ortiz, XR
    Shen, CL
    Murphy, RM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 311 - CHED
  • [4] Amyloid Beta in Aging and Alzheimer's Disease
    Sehar, Ujala
    Rawat, Priyanka
    Reddy, Arubala P.
    Kopel, Jonathan
    Reddy, P. Hemachandra
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [5] Amyloid Beta and MicroRNAs in Alzheimer's Disease
    Amakiri, Nnana
    Kubosumi, Aaron
    Tran, James
    Reddy, P. Hemachandra
    FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [6] Beta amyloid toxicity in Alzheimer's disease
    Gregory, GC
    Kwok, JB
    Xuereb, J
    Schofield, PR
    Halliday, GM
    NEUROBIOLOGY OF AGING, 2004, 25 : S157 - S158
  • [7] Inhibition of Amyloid-β Aggregation in Alzheimer's Disease
    Wang, Qiuming
    Yu, Xiang
    Li, Lingyan
    Zheng, Jie
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (08) : 1223 - 1243
  • [8] Screening for Novel Inhibitors of Amyloid Beta Aggregation and Toxicity as Potential Drugs for Alzheimer's Disease
    Sharari, Sanaa
    Vaikath, Nishant N.
    Tsakou, Magdalini
    Ghanem, Simona S.
    Vekrellis, Kostas
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (14)
  • [9] Amyloid-beta aggregation implicates multiple pathways in Alzheimer's disease: Understanding the mechanisms
    Iliyasu, Musa O.
    Musa, Sunday A.
    Oladele, Sunday B.
    Iliya, Abdullahi I.
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [10] Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer's Disease
    Re, F.
    Airoldi, C.
    Zona, C.
    Masserini, M.
    La Ferla, B.
    Quattrocchi, N.
    Nicotra, F.
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (27) : 2990 - 3006